Behrenbruch Christian - MD & Group CEO, Director at Telix Pharmaceuticals Ltd

Insider Transactions and Holdings

Entity Type
Individual
Role
MD & Group CEO, Director
Issuer Symbol
TLX on Nasdaq, TLPPF on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Behrenbruch Christian since 24 Apr 2025

Holdings reported by Behrenbruch Christian for Telix Pharmaceuticals Ltd

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 20,675,000 $155,476,000 $7.52 18 Mar 2026 Elk River Holdings Pty Ltd
Ordinary Shares 254,006 $1,910,125 $7.52 18 Mar 2026 Direct
American Depositary Receipts 400,000 18 Mar 2026 Direct

Transactions reported by Behrenbruch Christian for Telix Pharmaceuticals Ltd

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.